000 | 01668 a2200529 4500 | ||
---|---|---|---|
005 | 20250513071330.0 | ||
264 | 0 | _c19940217 | |
008 | 199402s 0 0 eng d | ||
022 | _a0364-5134 | ||
024 | 7 |
_a10.1002/ana.410350107 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDexter, D T | |
245 | 0 | 0 |
_aIndices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. _h[electronic resource] |
260 |
_bAnnals of neurology _cJan 1994 |
||
300 |
_a38-44 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a3,4-Dihydroxyphenylacetic Acid _xanalysis |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aBrain Chemistry |
650 | 0 | 4 |
_aCaudate Nucleus _xchemistry |
650 | 0 | 4 |
_aDopamine _xanalysis |
650 | 0 | 4 | _aElectron Transport |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFerritins _xanalysis |
650 | 0 | 4 |
_aGlutathione _xanalysis |
650 | 0 | 4 |
_aHomovanillic Acid _xanalysis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMetals _xanalysis |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMitochondria _xmetabolism |
650 | 0 | 4 | _aOxidation-Reduction |
650 | 0 | 4 |
_aParkinson Disease _xmetabolism |
650 | 0 | 4 |
_aPutamen _xchemistry |
650 | 0 | 4 |
_aSubstantia Nigra _xchemistry |
700 | 1 | _aSian, J | |
700 | 1 | _aRose, S | |
700 | 1 | _aHindmarsh, J G | |
700 | 1 | _aMann, V M | |
700 | 1 | _aCooper, J M | |
700 | 1 | _aWells, F R | |
700 | 1 | _aDaniel, S E | |
700 | 1 | _aLees, A J | |
700 | 1 | _aSchapira, A H | |
773 | 0 |
_tAnnals of neurology _gvol. 35 _gno. 1 _gp. 38-44 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/ana.410350107 _zAvailable from publisher's website |
999 |
_c8284871 _d8284871 |